Follow
Jeff Gehlhausen
Jeff Gehlhausen
Yale University School of Medicine
Verified email at yale.edu
Title
Cited by
Cited by
Year
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation
A Fernández-Castañeda, P Lu, AC Geraghty, E Song, MH Lee, J Wood, ...
Cell 185 (14), 2452-2468. e16, 2022
2922022
Distinguishing features of Long COVID identified through immune profiling
J Klein, J Wood, JR Jaycox, RM Dhodapkar, P Lu, JR Gehlhausen, ...
Nature 623 (7985), 139-148, 2023
2722023
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
C Lucas, CBF Vogels, I Yildirim, JE Rothman, P Lu, V Monteiro, ...
Nature 600 (7889), 523-529, 2021
2142021
Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain
A Fernández-Castañeda, P Lu, AC Geraghty, E Song, MH Lee, J Wood, ...
BioRxiv, 2022
902022
The tumor suppressor CDKN3 controls mitosis
G Nalepa, J Barnholtz-Sloan, R Enzor, D Dey, Y He, JR Gehlhausen, ...
Journal of Cell Biology 201 (7), 997-1012, 2013
892013
A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation
JR Gehlhausen, SJ Park, AE Hickox, M Shew, K Staser, SD Rhodes, ...
Human molecular genetics 24 (1), 1-8, 2015
772015
Gene networks in Drosophila melanogaster: integrating experimental data to predict gene function
JC Costello, MM Dalkilic, SM Beason, JR Gehlhausen, R Patwardhan, ...
Genome biology 10, 1-29, 2009
772009
The importance of nerve microenvironment for schwannoma development
A Schulz, R Büttner, C Hagel, SL Baader, L Kluwe, J Salamon, ...
Acta neuropathologica 132, 289-307, 2016
742016
Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
K Staser, SJ Park, SD Rhodes, Y Zeng, YZ He, MA Shew, JR Gehlhausen, ...
The Journal of clinical investigation 123 (1), 2012
522012
Discordant anti‐SARS‐CoV‐2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein
CJ Ko, M Harigopal, JR Gehlhausen, M Bosenberg, JM McNiff, W Damsky
Journal of Cutaneous Pathology 48 (1), 47-52, 2021
482021
Perniosis during the COVID‐19 pandemic: negative anti‐SARS‐CoV‐2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS‐CoV‐2
CJ Ko, M Harigopal, W Damsky, JR Gehlhausen, M Bosenberg, ...
Journal of Cutaneous Pathology 47 (11), 997-1002, 2020
222020
Lack of association between pandemic chilblains and SARS-CoV-2 infection
JR Gehlhausen, AJ Little, CJ Ko, M Emmenegger, C Lucas, P Wong, ...
Proceedings of the National Academy of Sciences 119 (9), e2122090119, 2022
182022
Toxoplasmosis: the heart of the diagnosis
JH England, SS Bailin, JR Gehlhausen, DH Rubin
Open forum infectious diseases 6 (1), ofy338, 2019
162019
Ketotifen modulates mast cell chemotaxis to kit-ligand, but does not impact mast cell numbers, degranulation, or tumor behavior in neurofibromas of NF1-deficient mice
CA Burks, SD Rhodes, WK Bessler, S Chen, A Smith, JR Gehlhausen, ...
Molecular cancer therapeutics 18 (12), 2321-2330, 2019
152019
Distinguishing features of Long COVID identified through immune profiling. medRxiv 2022
J Klein, J Wood, J Jaycox, P Lu, RM Dhodapkar, JR Gehlhausen, ...
Google Scholar, 0
15
PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2)
E Hawley, J Gehlhausen, S Karchugina, HY Chow, D Araiza-Olivera, ...
Human molecular genetics 30 (17), 1607-1617, 2021
142021
INPP5E preserves genomic stability through regulation of mitosis
EAS Potchanant, D Cerabona, ZA Sater, Y He, Z Sun, J Gehlhausen, ...
Molecular and cellular biology, 2017
142017
Focused update: guidelines of care for the management of actinic keratosis
DB Eisen, RP Dellavalle, L Frazer-Green, TE Schlesinger, M Shive, ...
Journal of the American Academy of Dermatology 87 (2), 373-374. e5, 2022
112022
Development or worsening of sarcoidosis associated with IL-17 blockade for psoriasis
N Hornick, A Wang, Y Lim, J Gehlhausen, J Siegel, J Wang, F Foss, I Lim, ...
Journal of the European Academy of Dermatology and Venereology: JEADV 34 (10 …, 2020
102020
Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2
BM Wahle, ET Hawley, Y He, AE Smith, J Yuan, AR Masters, DR Jones, ...
Oncotarget 9 (1), 718, 2018
92018
The system can't perform the operation now. Try again later.
Articles 1–20